182 related articles for article (PubMed ID: 25725454)
1. Rare disease policies to improve care for patients in Europe.
Rodwell C; Aymé S
Biochim Biophys Acta; 2015 Oct; 1852(10 Pt B):2329-35. PubMed ID: 25725454
[TBL] [Abstract][Full Text] [Related]
2. The European Union Policy in the Field of Rare Diseases.
Moliner AM; Waligora J
Adv Exp Med Biol; 2017; 1031():561-587. PubMed ID: 29214592
[TBL] [Abstract][Full Text] [Related]
3. Creating a European Union framework for actions in the field of rare diseases.
Moliner AM
Adv Exp Med Biol; 2010; 686():457-73. PubMed ID: 20824460
[TBL] [Abstract][Full Text] [Related]
4. The European union policy in the field of rare diseases.
Montserrat Moliner A; Waligóra J
Public Health Genomics; 2013; 16(6):268-77. PubMed ID: 24503587
[TBL] [Abstract][Full Text] [Related]
5. Fighting trafficking of falsified and substandard medicinal products in Russia.
Fayzrakhmanov NF
Int J Risk Saf Med; 2015; 27 Suppl 1():S37-40. PubMed ID: 26639702
[TBL] [Abstract][Full Text] [Related]
6. Review of 11 national policies for rare diseases in the context of key patient needs.
Dharssi S; Wong-Rieger D; Harold M; Terry S
Orphanet J Rare Dis; 2017 Mar; 12(1):63. PubMed ID: 28359278
[TBL] [Abstract][Full Text] [Related]
7. Drugs for rare diseases: mixed assessment in Europe.
Prescrire Int; 2007 Feb; 16(87):36-42. PubMed ID: 17323539
[TBL] [Abstract][Full Text] [Related]
8. Rare diseases and orphan drugs.
Taruscio D; Capozzoli F; Frank C
Ann Ist Super Sanita; 2011; 47(1):83-93. PubMed ID: 21430345
[TBL] [Abstract][Full Text] [Related]
9. Transposition and implementation of EU rare disease policy in Eastern Europe.
Pejcic AV; Iskrov G; Raycheva R; Stefanov R; Jakovljevic MM
Expert Rev Pharmacoecon Outcomes Res; 2017 Dec; 17(6):557-566. PubMed ID: 28975845
[TBL] [Abstract][Full Text] [Related]
10. Legal assessment of current situation on orphan patients in Lithuania.
Spokiene I
Medicina (Kaunas); 2008; 44(8):571-6. PubMed ID: 18791333
[TBL] [Abstract][Full Text] [Related]
11. Policies and actions to tackle rare diseases at European level.
Montserrat A; Taruscio D
Ann Ist Super Sanita; 2019; 55(3):296-304. PubMed ID: 31553326
[TBL] [Abstract][Full Text] [Related]
12. What is wrong with orphan drug policies? Suggestions for ways forward.
Kanavos P; Nicod E
Value Health; 2012 Dec; 15(8):1182-4. PubMed ID: 23244822
[TBL] [Abstract][Full Text] [Related]
13. [Hungarian national plan and strategy for rare diseases].
Kosztolányi G
Orv Hetil; 2014 Mar; 155(9):325-8. PubMed ID: 24566695
[TBL] [Abstract][Full Text] [Related]
14. Orphan drug development across Europe: bottlenecks and opportunities.
Heemstra HE; de Vrueh RL; van Weely S; Büller HA; Leufkens HG
Drug Discov Today; 2008 Aug; 13(15-16):670-6. PubMed ID: 18583178
[TBL] [Abstract][Full Text] [Related]
15. Rare Diseases in Europe: from a Wide to a Local Perspective.
Baldovino S; Moliner AM; Taruscio D; Daina E; Roccatello D
Isr Med Assoc J; 2016 Jun; 18(6):359-63. PubMed ID: 27468531
[TBL] [Abstract][Full Text] [Related]
16. European Medicines Agency support mechanisms fostering orphan drug development.
Butlen-Ducuing F; Rivière F; Aarum S; Llinares-Garcia J
Drug News Perspect; 2010; 23(1):71-81. PubMed ID: 20155221
[TBL] [Abstract][Full Text] [Related]
17. Issues surrounding orphan disease and orphan drug policies in Europe.
Denis A; Mergaert L; Fostier C; Cleemput I; Simoens S
Appl Health Econ Health Policy; 2010; 8(5):343-50. PubMed ID: 20804226
[TBL] [Abstract][Full Text] [Related]
18. [A proposal for reforming psychologists' training in France and in the European Union].
Bouchard JP
Encephale; 2009 Feb; 35(1):18-24. PubMed ID: 19250989
[TBL] [Abstract][Full Text] [Related]
19. How the EUCERD Joint Action supported initiatives on Rare Diseases.
Lynn S; Hedley V; Atalaia A; Evangelista T; Bushby K;
Eur J Med Genet; 2017 Mar; 60(3):185-189. PubMed ID: 28087401
[TBL] [Abstract][Full Text] [Related]
20. A Review of Rare Disease Policies and Orphan Drug Reimbursement Systems in 12 Eurasian Countries.
Czech M; Baran-Kooiker A; Atikeler K; Demirtshyan M; Gaitova K; Holownia-Voloskova M; Turcu-Stiolica A; Kooiker C; Piniazhko O; Konstandyan N; Zalis'ka O; Sykut-Cegielska J
Front Public Health; 2019; 7():416. PubMed ID: 32117845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
